Prior government service disclosed in an LDA filing; exact dates not reported
Executive Assistant to Rep. Greg Walden (06-10) Staff Assistant to Rep. Greg Walden (05-06)
Federal government
Inspect source ↗BLAIR C LARKINS appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.
Source-backed chronology
Prior government service disclosed in an LDA filing; exact dates not reported
Federal government
Inspect source ↗Documented in an LDA filing dated Jul 20, 2015
Federal LDA filings
Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages HR 1319 American Rescue Plan
LDA filing ↗Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages H.R. 133 Consolidated Appropriations Act, 2021
LDA filing ↗Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to prescription drug abuse and drug supply chain safety - no specific legislation Issues related to PBM's - no specific legislation Issues related to preferred pharmacy networks, mail order and incentives
LDA filing ↗Registrant: BOCKORNY GROUP, INC. · Health Issues
Issues related to the corporate business model, Medicare Part D and anti-PBM legislation Issues related to health care delivery system reforms, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices Privacy issues relating to the use of protected health information Issues Related to Telehealth Issues Related to Smoking Cessation Initiatives
LDA filing ↗Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements
LDA filing ↗Registrant: BOCKORNY GROUP, INC. · Health Issues
H.R.6 - 21st Century Cures Act H.R.793 - Ensuring Seniors Access to Local Pharmacies Act of 2015 H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015 Issues related to the corporate business model, smoking cessation, Medicare Part D and anti-PBM legislation Issues related to health care delivery system reforms including telehealth, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices Privacy issues relating to the use of protected health information Issues related to Federal Employees Health Benefit Plan Issues related to Medicare/Medicaid plan design, reimbursement, cost savings proposals, and SGR
LDA filing ↗Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBM's - no specific legislation Issues related to preferred pharmacy networks, mail order and incentives Issues related to prescription drug abuse, pharmacist provider status, drug pricing and drug supply chain safety. H.R.1600 - A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. H.R.804 - Expanding the Availability of Medicare Data Act H.R.592 - Pharmacy and Medically Underserved Areas Enhancement Act S.314 - Pharmacy and Medically Underserved Areas Enhancement Act H.R.244 - MAC Transparency Act H.R.1021 - Protecting the Integrity of Medicare Act of 2015 S.776 - Medication Therapy Management Empowerment Act of 2015 H.R.471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015
LDA filing ↗Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBM's - no specific legislation Issues related to preferred pharmacy networks, mail order and incentives Issues related to prescription drug abuse, pharmacist provider status, drug pricing and drug supply chain safety. H.R.1600 - A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. H.R.804 - Expanding the Availability of Medicare Data Act H.R.592 - Pharmacy and Medically Underserved Areas Enhancement Act S.314 - Pharmacy and Medically Underserved Areas Enhancement Act H.R.244 - MAC Transparency Act H.R.1021 - Protecting the Integrity of Medicare Act of 2015 S.776 - Medication Therapy Management Empowerment Act of 2015 H.R.471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015
LDA filing ↗Registrant: BOCKORNY GROUP, INC. · Health Issues
H.R.6 - 21st Century Cures Act H.R.793 - Ensuring Seniors Access to Local Pharmacies Act of 2015 H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015 Issues related to the corporate business model, smoking cessation, Medicare Part D and anti-PBM legislation Issues related to health care delivery system reforms including telehealth, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices Privacy issues relating to the use of protected health information Issues related to Federal Employees Health Benefit Plan Issues related to Medicare/Medicaid plan design, reimbursement, cost savings proposals, and SGR Issues related to home infusion
LDA filing ↗Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages
LDA filing ↗Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements
LDA filing ↗Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages HR 1319 American Rescue Plan
LDA filing ↗Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages H.R. 133 Consolidated Appropriations Act, 2021
LDA filing ↗Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages HR 1319 American Rescue Plan
LDA filing ↗Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages
LDA filing ↗Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements
LDA filing ↗